Direct Peritoneal Resuscitation Alters Hepatic miRNA Expression after Hemorrhagic Shock

Jessica L Weaver1, Paul J Matheson1, Ryan T Hurt2

  • 1Department of Surgery, University of Louisville, Louisville, KY; Robley Rex Veterans Affairs Medical Center, Louisville, KY.

Abstract

Insights

Direct peritoneal resuscitation (DPR) significantly downregulates hepatic microRNAs (miRNAs) after hemorrhagic shock (HS). This suggests DPR may reduce liver inflammation and improve outcomes in HS patients.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Physiology

Background:

  • MicroRNAs (miRNAs) are crucial regulators of gene expression and cellular processes, including inflammation.
  • Hemorrhagic shock (HS) triggers inflammatory responses, and hepatic miRNAs play a role in this cascade.
  • Direct peritoneal resuscitation (DPR) is an adjunct therapy to conventional resuscitation (CR) that improves visceral blood flow and reduces pro-inflammatory cytokines in HS.

Purpose of the Study:

  • To investigate the impact of DPR on hepatic miRNA expression patterns following resuscitated HS.
  • To determine if DPR alters the expression of specific miRNAs involved in inflammatory pathways.

Main Methods:

  • Male Sprague-Dawley rats underwent sham operation, CR, or CR with DPR (CR + peritoneal dialysis solution).
  • Animals were sacrificed at 4 hours post-resuscitation.
  • Hepatic miRNA expression was quantified using reverse transcription polymerase chain reaction (RT-PCR).

Main Results:

  • DPR treatment resulted in the downregulation of 68 out of 92 hepatic miRNAs compared to CR alone (p < 0.01).
  • Conversely, only 2 miRNAs were upregulated with DPR compared to CR.
  • Specific miRNAs, including miR-9-5p, miR-122-5p, and miR-146 (regulating NFκB), were significantly downregulated with DPR.

Conclusions:

  • Direct peritoneal resuscitation (DPR) broadly downregulates hepatic miRNA expression following hemorrhagic shock (HS).
  • This global miRNA modulation suggests targeted effects on specific inflammatory pathways.
  • DPR may serve as a therapeutic strategy to mitigate hepatic inflammation and enhance patient recovery after HS.